Implications of antineutrophil cytoplasmic antibody status when switching to maintenance therapy

Arthritis Rheum. 2005 Feb 15;53(1):1-2. doi: 10.1002/art.20921.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antibodies, Antineutrophil Cytoplasmic / immunology*
  • Antirheumatic Agents / therapeutic use*
  • Arthritis / drug therapy*
  • Arthritis / immunology*
  • Humans

Substances

  • Antibodies, Antineutrophil Cytoplasmic
  • Antirheumatic Agents